“…First, a combination of cement spacer and induced membrane is used to fill the defected area . Second, a biological implant replaces the cement spacer, which is impermeable, biological, and vascular-active . However, autografts present some limitations such as morbidity in the donor site, pain, long hospitalization time, limited quantity, needing general anesthesia during the surgery, extended nonweight-bearing, graft hypertrophy, and the risk of hematoma and deep infection. , Therefore, it is clear that novel bone replacements are highly demanded and must be bioactive, biodegradable, biocompatible, bespoke, resistant to infections, cost-effective, and have high porosity to enable cell attachment and vascularization, providing similar mechanical and biological properties as bone tissue. , …”